Skip to main content
Premium Trial:

Request an Annual Quote

Pangea Releases Latest Version of GeneWorld Database Application

Premium

OAKLAND, Calif.--Pangea Systems Inc. has released GeneWorld 2.1, the latest version of its database application for automated sequence annotation and analysis. GeneWorld 2.1 utilizes simplified, user-definable, automated workflow processes, which the company calls strategies. Once defined, strategies can be saved and used for standardizing and distributing bioinformatics information throughout an organization.

GeneWorld 2.1 is based on Oracle or Sybase relational database systems and is accessed from desktop computers with standard Java-enabled browsers.

In other news, Pangea also announced the formation of a scientific advisory board. Members include Fred Cohen of the University of California, San Francisco; Barry Honig of Columbia University; and Doug Brutlag of the Stanford University Medical School.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.